- Home
- VTYX vs NNY Comparison
VTYX vs NNY Comparison
Compare VTYX & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- NNY
- Stock Information
- Founded
- VTYX 2018
- NNY 1987
- Country
- VTYX United States
- NNY United States
- Employees
- VTYX N/A
- NNY N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- NNY Investment Managers
- Sector
- VTYX Health Care
- NNY Finance
- Exchange
- VTYX Nasdaq
- NNY Nasdaq
- Market Cap
- VTYX 154.9M
- NNY 155.1M
- IPO Year
- VTYX 2021
- NNY N/A
- Fundamental
- Price
- VTYX $1.70
- NNY $8.18
- Analyst Decision
- VTYX Buy
- NNY
- Analyst Count
- VTYX 4
- NNY 0
- Target Price
- VTYX $11.33
- NNY N/A
- AVG Volume (30 Days)
- VTYX 1.5M
- NNY 50.9K
- Earning Date
- VTYX 05-08-2025
- NNY 01-01-0001
- Dividend Yield
- VTYX N/A
- NNY 4.04%
- EPS Growth
- VTYX N/A
- NNY N/A
- EPS
- VTYX N/A
- NNY N/A
- Revenue
- VTYX N/A
- NNY N/A
- Revenue This Year
- VTYX N/A
- NNY N/A
- Revenue Next Year
- VTYX N/A
- NNY N/A
- P/E Ratio
- VTYX N/A
- NNY N/A
- Revenue Growth
- VTYX N/A
- NNY N/A
- 52 Week Low
- VTYX $0.78
- NNY $7.58
- 52 Week High
- VTYX $5.66
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- VTYX 61.97
- NNY 48.19
- Support Level
- VTYX $1.68
- NNY $8.09
- Resistance Level
- VTYX $1.85
- NNY $8.79
- Average True Range (ATR)
- VTYX 0.15
- NNY 0.23
- MACD
- VTYX 0.04
- NNY -0.01
- Stochastic Oscillator
- VTYX 67.05
- NNY 22.47
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.